Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs

Transplant Proc. 1992 Feb;24(1):105-6.
No abstract available

MeSH terms

  • Alprostadil / administration & dosage
  • Alprostadil / therapeutic use*
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / etiology
  • Estradiol / blood
  • Follicle Stimulating Hormone / blood
  • Humans
  • Kidney Transplantation / physiology*
  • Luteinizing Hormone / blood
  • Male
  • Middle Aged
  • Papaverine / administration & dosage
  • Papaverine / therapeutic use*
  • Penile Erection / drug effects*
  • Prolactin / blood
  • Renal Dialysis
  • Retrospective Studies
  • Testosterone / blood
  • Vasoconstrictor Agents / administration & dosage
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Vasoconstrictor Agents
  • Testosterone
  • Estradiol
  • Prolactin
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Papaverine
  • Alprostadil